Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
Main Authors: | Welinder, Charlotte, Jönsson, Göran, Ingvar, Christian, Lundgren, Lotta, Olsson, Håkan, Breslin, Thomas, Végvári, Ákos, Laurell, Thomas, Rezeli, Melinda, Jansson, Bo, Baldetorp, Bo, Marko-Varga, György |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599425/ |
Similar Items
-
Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
by: Welinder, Charlotte, et al.
Published: (2014) -
A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
by: Welinder, Charlotte, et al.
Published: (2015) -
Biobank resources for future patient care: developments, principles and concepts
by: Végvári, Ákos, et al.
Published: (2011) -
Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
by: Rezeli, Melinda, et al.
Published: (2011) -
Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
by: Marko-Varga, György, et al.
Published: (2012)